Pathology of human plaque vulnerability: Mechanisms and consequences of intraplaque haemorrhages

Atherosclerosis

Volumn 234, Issue 2, 2014, Pages 311-319

  Michel, Jean Baptiste ^a   Martin Ventura, José Luis ^b   Nicoletti, Antonino ^a   Ho Tin Noé, Benoit ^a  

^a Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

Author keywords

Neo angiogenesis; Phagocytosis; Proteases; Red blood cells

Indexed keywords

CEROID; CHOLESTEROL; GLYCOPHORIN A; HEMOGLOBIN; IRON; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; VASCULOTROPIN; ANGIOGENIC PROTEIN; BIOLOGICAL MARKER;

ADVENTITIA; ANGIOGENESIS; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BLEEDING; CELL MEMBRANE; ERYTHROCYTE; HISTOPATHOLOGY; HUMAN; INTRAPLAQUE HEMORRHAGE; LEUKOCYTE; MOLECULAR IMAGING; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE; VASCULAR SMOOTH MUSCLE; ARTERY; ATHEROSCLEROSIS; DISEASE COURSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; RUPTURE;

ANGIOGENIC PROTEINS; ARTERIES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ERYTHROCYTES; HEMORRHAGE; HUMANS; MOLECULAR IMAGING; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; RUPTURE, SPONTANEOUS;

EID: 84900865991     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.03.020     Document Type: Review

References (109)

1. Minino A.M. Death in the United States, 2009. NCHS Data Brief 2011, 1-8.
2. Fogelstrand P., Boren J. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis. Nutr Metab Cardiovasc Dis 2012, 22:1-7.
3. Caro C.G., Lever M.J. Factors influencing arterial wall mass transport. Biorheology 1984, 21:197-205.
4. Michel J.B., Thaunat O., Houard X., Meilhac O., Caligiuri G., Nicoletti A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol 2007, 27:1259-1268.
5. Jackson R.L., Busch S.J., Cardin A.D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991, 71:481-539.
6. Tabas I., Williams K.J., Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007, 116:1832-1844.
7. Olofsson S.O., Boren J. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. JIntern Med 2005, 258:395-410.
8. Camejo G., Halberg C., Manschik-Lundin A., Hurt-Camejo E., Rosengren B., Olsson H., et al. Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. JLipid Res 1998, 39:755-766.
9. Nagy E., Eaton J.W., Jeney V., Soares M.P., Varga Z., Galajda Z., et al. Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol 2010, 30:1347-1353.
10. Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation; in press.
11. Parker F., Odland G.F. Acorrelative histochemical, biochemical and electron microscopic study of experimental atherosclerosis in the rabbit aorta with special reference to the myo-intimal cell. Am J Pathol 1966, 48:197-239.
12. Goldstein J.L., Anderson R.G., Buja L.M., Basu S.K., Brown M.S. Overloading human aortic smooth muscle cells with low density lipoprotein-cholesteryl esters reproduces features of atherosclerosis invitro. JClin Invest 1977, 59:1196-1202.
13. Katsuda S., Boyd H.C., Fligner C., Ross R., Gown A.M. Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol 1992, 140:907-914.
14. Kockx M.M., De Meyer G.R., Muhring J., Jacob W., Bult H., Herman A.G. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 1998, 97:2307-2315.
15. Van Herck J.L., De Meyer G.R., Martinet W., Van Hove C.E., Foubert K., Theunis M.H., et al. Impaired fibrillin-1 function promotes features of plaque instability in apolipoprotein E-deficient mice. Circulation 2009, 120:2478-2487.
16. Van der Donckt C, Van Herck JL, Schrijvers DM, Vanhoutte G, Verhoye M, Blockx I, et al. Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death. Eur Heart J; in press.
17. Burke A.P., Kolodgie F.D., Farb A., Weber D.K., Malcom G.T., Smialek J., et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001, 103:934-940.
18. Walker B., Towhid S.T., Schmid E., Hoffmann S.M., Abed M., Munzer P., et al. Dynamic adhesion of eryptotic erythrocytes to immobilized platelets via platelet phosphatidylserine receptors. Am J Physiol Cell Physiol 2013, 306(3):C291-C297.
19. Duguid J.B. The thrombogenic hypothesis and its implications. Postgrad Med J 1960, 36:226-229.
20. Arbustini E., Morbini P., D'Armini A.M., Repetto A., Minzioni G., Piovella F., et al. Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart 2002, 88:177-182.
21. Paterson J.C. Vascularization and hemorrhage of the intima of coronary atherosclerotic arteries. Arch Pathol 1936, 22:312-324.
22. Wartman W.B. Occlusion of the coronary arteries by hemorrhage into their walls. Am Heart J 1938, 5:459-470.
23. Kolodgie F.D., Gold H.K., Burke A.P., Fowler D.R., Kruth H.S., Weber D.K., et al. Intraplaque hemorrhage and progression of coronary atheroma. NEngl J Med 2003, 349:2316-2325.
24. Hellings W.E., Peeters W., Moll F.L., Piers S.R., van Setten J., Van der Spek P.J., et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010, 121:1941-1950.
25. Takaya N., Yuan C., Chu B., Saam T., Polissar N.L., Jarvik G.P., et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 2005, 111:2768-2775.
26. Michel J.B., Virmani R., Arbustini E., Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 2011, 32:1977-1985. 1985a, 1985b, 1985c.
27. Michel J.B., Delbosc S., Ho-Tin-Noe B., Leseche G., Nicoletti A., Meilhac O., et al. From intraplaque haemorrhages to plaque vulnerability: biological consequences of intraplaque haemorrhages. JCardiovasc Med (Hagerstown) 2012, 13:628-634.
28. Vrijenhoek J.E., Den Ruijter H.M., De Borst G.J., de Kleijn D.P., De Vries J.P., Bots M.L., et al. Sex is associated with the presence of atherosclerotic plaque hemorrhage and modifies the relation between plaque hemorrhage and cardiovascular outcome. Stroke 2013, 44:3318-3323.
29. Cheng C., Chrifi I., Pasterkamp G., Duckers H.J. Biological mechanisms of microvessel formation in advanced atherosclerosis: the big five. Trends Cardiovasc Med 2013, 23:153-164.
30. Marsch E., Sluimer J.C., Daemen M.J. Hypoxia in atherosclerosis and inflammation. Curr Opin Lipidol 2013, 24:393-400.
31. Lim C.S., Kiriakidis S., Sandison A., Paleolog E.M., Davies A.H. Hypoxia-inducible factor pathway and diseases of the vascular wall. JVasc Surg 2013, 58:219-230.
32. Silvola J.M., Saraste A., Forsback S., Laine V.J., Saukko P., Heinonen S.E., et al. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice. Arterioscler Thromb Vasc Biol 2011, 31:1011-1015.
33. Sluimer J.C., Gasc J.M., van Wanroij J.L., Kisters N., Groeneweg M., Sollewijn Gelpke M.D., et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. JAm Coll Cardiol 2008, 51:1258-1265.
34. Ho-Tin-Noe B., Michel J.B. Initiation of angiogenesis in atherosclerosis: smooth muscle cells as mediators of the angiogenic response to atheroma formation. Trends Cardiovasc Med 2011, 21:183-187.
35. Tanaka K., Nagata D., Hirata Y., Tabata Y., Nagai R., Sata M. Augmented angiogenesis in adventitia promotes growth of atherosclerotic plaque in apolipoprotein E-deficient mice. Atherosclerosis 2011, 215:366-373.
36. Ho-Tin-Noe B., Le Dall J., Gomez D., Louedec L., Vranckx R., El-Bouchtaoui M., et al. Early atheroma-derived agonists of peroxisome proliferator-activated receptor-{gamma} trigger intramedial angiogenesis in a smooth muscle cell-dependent manner. Circ Res 2011, 109:1003-1014.
37. Kansanen E., Kivela A.M., Levonen A.L. Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2. Free Radic Biol Med 2009, 47:1310-1317.
38. Kapadia R., Yi J.H., Vemuganti R. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 2008, 13:1813-1826.
39. Le Dall J., Ho-Tin-Noe B., Louedec L., Meilhac O., Roncal C., Carmeliet P., et al. Immaturity of microvessels in haemorrhagic plaques is associated withproteolytic degradation of angiogenic factors. Cardiovasc Res 2010, 85:184-193.
40. Fontaine V., Touat Z., Mtairag el M., Vranckx R., Louedec L., Houard X., et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol 2004, 164:2077-2087.
41. Langlois M.R., Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996, 42:1589-1600.
42. Costacou T., Levy A.P. Haptoglobin genotype and its role in diabetic cardiovascular disease. JCardiovasc Transl Res 2012, 5:423-435.
43. Ijas P., Saksi J., Soinne L., Tuimala J., Jauhiainen M., Jula A., et al. Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. Atherosclerosis 2013, 230:228-234.
44. Meyrier A. Cholesterol crystal embolism: diagnosis and treatment. Kidney Int 2006, 69:1308-1312.
45. Burt R.C. The incidence of acid-fast pigment (ceroid) in aortic atherosclerosis. Am J Clin Pathol 1952, 22:135-139.
46. Mitchinson M.J., Hothersall D.C., Brooks P.N., De Burbure C.Y. The distribution of ceroid in human atherosclerosis. JPathol 1985, 145:177-183.
47. Ball R.Y., Carpenter K.L., Mitchinson M.J. What is the significance of ceroid in human atherosclerosis?. Arch Pathol Lab Med 1987, 111:1134-1140.
48. Wen Y., Leake D.S. Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ Res 2007, 100:1337-1343.
49. Lee F.Y., Lee T.S., Pan C.C., Huang A.L., Chau L.Y. Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis 1998, 138:281-288.
50. Haka A.S., Kramer J.R., Dasari R.R., Fitzmaurice M. Mechanism of ceroid formation in atherosclerotic plaque: in situ studies using a combination of Raman and fluorescence spectroscopy. JBiomed Opt 2011, 16:011011.
51. Li W., Ostblom M., Xu L.H., Hellsten A., Leanderson P., Liedberg B., et al. Cytocidal effects of atheromatous plaque components: the death zone revisited. FASEB J 2006, 20:2281-2290.
52. Parums D.V., Chadwick D.R., Mitchinson M.J. The localisation of immunoglobulin in chronic periaortitis. Atherosclerosis 1986, 61:117-123.
53. Parums D.V., Brown D.L., Mitchinson M.J. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 1990, 114:383-387.
54. Meier P., Vogt B., Blanc E. Rethinking the triggering inflammatory processes of chronic periaortitis. Nephron Exp Nephrol 2007, 105:e17-23.
55. Alberti C. Retroperitoneal fibroses: aetiopathogenesis and taxonomic assessment. Eur Rev Med Pharmacol Sci 2007, 11:375-382.
56. Li W., Hellsten A., Xu L.H., Zhuang D.M., Jansson K., Brunk U.T., et al. Foam cell death induced by 7beta-hydroxycholesterol is mediated by labile iron-driven oxidative injury: mechanisms underlying induction of ferritin in human atheroma. Free Radic Biol Med 2005, 39:864-875.
57. Yuan X.M., Anders W.L., Olsson A.G., Brunk U.T. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. Atherosclerosis 1996, 124:61-73.
58. Kolb S., Vranckx R., Huisse M.G., Michel J.B., Meilhac O. The phosphatidylserine receptor mediates phagocytosis by vascular smooth muscle cells. JPathol 2007, 212:249-259.
59. Buttari B., Profumo E., Businaro R., Saso L., Capoano R., Salvati B., et al. Oxidized haemoglobin-driven endothelial dysfunction and immune cell activation: novel therapeutic targets for atherosclerosis. Curr Med Chem 2013, 20:4806-4814.
60. Leclercq A., Houard X., Philippe M., Ollivier V., Sebbag U., Meilhac O., et al. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. JLeukoc Biol 2007, 82:1420-1429.
61. Modi W.S., Yoshimura T. Isolation of novel GRO genes and a phylogenetic analysis of the CXC chemokine subfamily in mammals. Mol Biol Evol 1999, 16:180-193.
62. Houard X., Rouzet F., Touat Z., Philippe M., Dominguez M., Fontaine V., et al. Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. JPathol 2007, 212:20-28.
63. Houard X., Touat Z., Ollivier V., Louedec L., Philippe M., Sebbag U., et al. Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res 2009, 82:532-541.
64. Borregaard N., Cowland J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997, 89:3503-3521.
65. Logters T., Margraf S., Altrichter J., Cinatl J., Mitzner S., Windolf J., et al. The clinical value of neutrophil extracellular traps. Med Microbiol Immunol 2009, 198(4):211-219.
66. Borissoff J.I., Joosen I.A., Versteylen M.O., Brill A., Fuchs T.A., Savchenko A.S., et al. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 2013, 33:2032-2040.
67. Saffarzadeh M., Juenemann C., Queisser M.A., Lochnit G., Barreto G., Galuska S.P., et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012, 7:e32366.
68. Hunter A.C. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev 2006, 58:1523-1531.
69. Engelmann B., Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013, 13:34-45.
70. Fuchs T.A., Bhandari A.A., Wagner D.D. Histones induce rapid and profound thrombocytopenia in mice. Blood 2011, 118:3708-3714.
71. Borissoff J.I., Spronk H.M., ten Cate H. The hemostatic system as a modulator of atherosclerosis. NEngl J Med 2011, 364:1746-1760.
72. Massberg S., Grahl L., von Bruehl M.L., Manukyan D., Pfeiler S., Goosmann C., et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010, 16:887-896.
73. Chandler A.B., Hand R.A. Phagocytized platelets: a source of lipids in human thrombi and atherosclerotic plaques. Science 1961, 134:946-947.
74. Kruth H.S. Platelet-mediated cholesterol accumulation in cultured aortic smooth muscle cells. Science 1985, 227:1243-1245.
75. Mansilla S., Boulaftali Y., Venisse L., Arocas V., Meilhac O., Michel J.B., et al. Macrophages and platelets are the major source of protease nexin-1 in human atherosclerotic plaque. Arterioscler Thromb Vasc Biol 2008, 28:1844-1850.
76. Delbosc S., Alsac J.M., Journe C., Louedec L., Castier Y., Bonnaure-Mallet M., et al. Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats. PLoS One 2011, 6:e18679.
77. Pessi T., Karhunen V., Karjalainen P.P., Ylitalo A., Airaksinen J.K., Niemi M., et al. Bacterial signatures in thrombus aspirates of patients with myocardial infarction. Circulation 2013, 127:1219-1228. e1211-1216.
78. Koren O., Spor A., Felin J., Fak F., Stombaugh J., Tremaroli V., et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A 2011, 108(Suppl.1):4592-4598.
79. Fifer K.M., Qadir S., Subramanian S., Vijayakumar J., Figueroa A.L., Truong Q.A., et al. Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation. JAm Coll Cardiol 2011, 57:971-976.
80. Tufano A., Di Capua M., Coppola A., Conca P., Cimino E., Cerbone A.M., et al. The infectious burden in atherothrombosis. Semin Thromb Hemost 2012, 38:515-523.
81. Mocsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. JExp Med 2013, 210:1283-1299.
82. K. Martinod and D.D. Wagner, Thrombosis: tangled up in NETs, Blood; in press.
83. Chaput C., Zychlinsky A. Sepsis: the dark side of histones. Nat Med 2009, 15:1245-1246.
84. Haskard D.O., Boyle J.J., Evans P.C., Mason J.C., Randi A.M. Cytoprotective signaling and gene expression in endothelial cells and macrophages-lessons for atherosclerosis. Microcirculation 2013, 20:203-216.
85. Boyle J.J., Harrington H.A., Piper E., Elderfield K., Stark J., Landis R.C., et al. Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol 2009, 174:1097-1108.
86. Boyle J.J., Johns M., Lo J., Chiodini A., Ambrose N., Evans P.C., et al. Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2011, 31:2685-2691.
87. Finn A.V., Nakano M., Polavarapu R., Karmali V., Saeed O., Zhao X., et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. JAm Coll Cardiol 2012, 59:166-177.
88. Bories G., Colin S., Vanhoutte J., Derudas B., Copin C., Fanchon M., et al. Liver X receptor activation stimulates iron export in human alternative macrophages. Circ Res 2013, 113:1196-1205.
89. Schwake M., Schroder B., Saftig P. Lysosomal membrane proteins and their central role in physiology. Traffic 2013, 14:739-748.
90. Andreeva E.R., Pugach I.M., Orekhov A.N. Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and invitro. Atherosclerosis 1997, 135:19-27.
91. Rong J.X., Shapiro M., Trogan E., Fisher E.A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci U S A 2003, 100:13531-13536.
92. Bennett M.R. Cell death in cardiovascular disease. Arterioscler Thromb Vasc Biol 2011, 31:2779-2780.
93. Gomez D., Shankman L.S., Nguyen A.T., Owens G.K. Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods 2013, 10:171-177.
94. Martin-Ventura J.L., Blanco-Colio L.M., Tunon J., Gomez-Guerrero C., Michel J.B., Meilhac O., et al. Proteomics in atherothrombosis: a future perspective. Expert Rev Proteomics 2007, 4:249-260.
95. Martin-Ventura J.L., Nicolas V., Houard X., Blanco-Colio L.M., Leclercq A., Egido J., et al. Biological significance of decreased HSP27 in human atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:1337-1343.
96. Kardys I., Rifai N., Meilhac O., Michel J.B., Martin-Ventura J.L., Buring J.E., et al. Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study. Clin Chem 2008, 54:139-146.
97. Alfakry H., Sinisalo J., Paju S., Nieminen M.S., Valtonen V., Tervahartiala T., et al. The association of serum neutrophil markers and acute coronary syndrome. Scand J Immunol 2012, 76:181-187.
98. Moreno J.A., Ortega-Gomez A., Delbosc S., Beaufort N., Sorbets E., Louedec L., et al. Invitro and invivo evidence for the role of elastase shedding of CD163 in human atherothrombosis. Eur Heart J 2012, 33:252-263.
99. Coli S., Magnoni M., Sangiorgi G., Marrocco-Trischitta M.M., Melisurgo G., Mauriello A., et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. JAm Coll Cardiol 2008, 52:223-230.
100. Staub D., Partovi S., Schinkel A.F., Coll B., Uthoff H., Aschwanden M., et al. Correlation of carotid artery atherosclerotic lesion echogenicity and severity at standard US with intraplaque neovascularization detected at contrast-enhanced US. Radiology 2011, 258:618-626.
101. Ten Kate G.L., van den Oord S.C., Sijbrands E.J., van der Lugt A., de Jong N., Bosch J.G., et al. Current status and future developments of contrast-enhanced ultrasound of carotid atherosclerosis. JVasc Surg 2013, 57:539-546.
102. Khanicheh E., Qi Y., Xie A., Mitterhuber M., Xu L., Mochizuki M., et al. Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties. Arterioscler Thromb Vasc Biol 2013, 33:2187-2192.
103. Kerwin W., Hooker A., Spilker M., Vicini P., Ferguson M., Hatsukami T., et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003, 107:851-856.
104. Gaens M.E., Backes W.H., Rozel S., Lipperts M., Sanders S.N., Jaspers K., et al. Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: model selection, reproducibility, and validation. Radiology 2013, 266:271-279.
105. Masteling M.G., Zeebregts C.J., Tio R.A., Breek J.C., Tietge U.J., de Boer J.F., et al. High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability. JNucl Cardiol 2011, 18:1066-1075.
106. Courtois A., Nusgens B.V., Hustinx R., Namur G., Gomez P., Somja J., et al. 18F-FDG uptake assessed by PET/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. JNucl Med 2013, 54:1740-1747.
107. Erlandsson K., Buvat I., Pretorius P.H., Thomas B.A., Hutton B.F. Areview of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology. Phys Med Biol 2012, 57:R119-R159.
108. Rouzet F., Bachelet-Violette L., Alsac J.M., Suzuki M., Meulemans A., Louedec L., et al. Radiolabeled fucoidan as a P-Selectin targeting agent for invivo imaging of platelet-rich thrombus and endothelial activation. JNucl Med 2011, 52:1433-1440.
109. Li L., Li Y.W., Zhao J.Y., Liu Y.Z., Holscher C. Quantitative analysis of iron concentration and expression of ferroportin 1 in the cortex and hippocampus of rats induced by cerebral ischemia. JClin Neurosci 2009, 16:1466-1472.